Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors

Published:2024-07-25 Issue:3-4 Volume:46 Page:
ISSN:1863-2297
Container-title:Seminars in Immunopathology
language:en
Short-container-title:Semin Immunopathol

Author:

Spiga Martina,Martini Elisa,Maffia Maria Chiara,Ciceri Fabio,Ruggiero Eliana,Potenza Alessia,Bonini Chiara

Funder

Fondazione AIRC per la ricerca sul cancro ETS

Ministero dell’Istruzione, dell’Università e della Ricerca

Ministero della Salute

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00281-024-01011-y.pdf

Reference266 articles.

1. Rosenberg SA et al (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 319(25):1676–1680. https://doi.org/10.1056/NEJM198812223192527

2. Ben-Avi R et al (2018) Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients. Cancer Immunol Immunother 67(8):1221–1230. https://doi.org/10.1007/s00262-018-2174-4

3. Dudley ME et al (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594):850–854. https://doi.org/10.1126/science.1076514

4. Manfredi F et al (2020) TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals. Front Immunol 11. Accessed: Dec. 28, 2022. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fimmu.2020.01689

5. Alnefaie A et al (2022) Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. Front Bioeng Biotechnol 10. Accessed: Jan. 09, 2023. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fbioe.2022.797440

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3